{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:13:55Z","timestamp":1792793635821,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K08 NS901527"],"award-info":[{"award-number":["K08 NS901527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.nec.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:06:55Z","timestamp":1599757615000},"page":"613-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Leptomeningeal Carcinomatosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Hriday P.","family":"Bhambhvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine C.","family":"Umeh-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hayden Gephart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.nec.2020.06.010_bib1","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib2","first-page":"362","article-title":"Leptomeningeal disease and the evolving role of molecular targeted therapy and immunotherapy","volume":"17","author":"Thomas","year":"2017","journal-title":"Ochsner J"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","article-title":"Leptomeningeal metastasis: survival and prognostic factors in 155 patients","volume":"223","author":"Herrlinger","year":"2004","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.nec.2020.06.010_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nec.2010.08.006","article-title":"Leptomeningeal disease","volume":"22","author":"Groves","year":"2011","journal-title":"Neurosurg Clin N Am"},{"issue":"Suppl 4","key":"10.1016\/j.nec.2020.06.010_bib6","first-page":"S265","article-title":"Carcinomatous meningitis: leptomeningeal metastases in solid tumors","volume":"4","author":"Le Rhun","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/157339411797642597","article-title":"Leptomeningeal metastasis: challenges in diagnosis and treatment","volume":"7","author":"Leal","year":"2011","journal-title":"Curr Cancer Ther Rev"},{"issue":"7","key":"10.1016\/j.nec.2020.06.010_bib9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","article-title":"Leptomeningeal carcinomatosis: presenting features and prognostic factors","volume":"53","author":"Balm","year":"1996","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E","article-title":"Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival","volume":"42","author":"Amer","year":"1978","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005792-198201000-00005","article-title":"Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience","volume":"61","author":"Rosen","year":"1982","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/1097-0142(197807)42:1<283::AID-CNCR2820420142>3.0.CO;2-#","article-title":"Meningeal carcinomatosis in breast cancer","volume":"42","author":"Yap","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.nec.2020.06.010_bib13","series-title":"Neurologic complications of cancer (Contemporary neurology series)","author":"DeAngelis","year":"2009"},{"issue":"12","key":"10.1016\/j.nec.2020.06.010_bib14","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B","article-title":"Central nervous system metastasis from breast carcinoma. Autopsy study","volume":"52","author":"Tsukada","year":"1983","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9343(81)90254-0","article-title":"Meningeal carcinomatosis in small cell carcinoma of the lung","volume":"71","author":"Aroney","year":"1981","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12032-012-0408-4","article-title":"Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival","volume":"30","author":"Niwi\u0144ska","year":"2013","journal-title":"Med Oncol"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib17","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"13","key":"10.1016\/j.nec.2020.06.010_bib18","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1016\/S1470-2045(14)70364-X","article-title":"Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry","volume":"15","author":"Brewster","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nec.2020.06.010_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J\u00a0Neurooncol"},{"issue":"10","key":"10.1016\/j.nec.2020.06.010_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nec.2020.06.010_bib21","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"18","key":"10.1016\/j.nec.2020.06.010_bib22","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the MRI era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-008-9758-3","article-title":"Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors","volume":"93","author":"Waki","year":"2009","journal-title":"J\u00a0Neurooncol"},{"issue":"653","key":"10.1016\/j.nec.2020.06.010_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/pgmj.56.653.149","article-title":"Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases","volume":"56","author":"Boyle","year":"1980","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib25","first-page":"248","article-title":"Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa","volume":"108","author":"Suki","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1227\/01.NEU.0000341535.53720.3E","article-title":"Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis","volume":"64","author":"Suki","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2020.06.010_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2015.07.027","article-title":"A\u00a0balanced view of the cerebrospinal fluid composition and functions: focus on adult humans","volume":"273","author":"Spector","year":"2015","journal-title":"Exp Neurol"},{"issue":"26","key":"10.1016\/j.nec.2020.06.010_bib28","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis","volume":"359","author":"Chiang","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1078-0432.CCR-17-1582","article-title":"Cell-cycle and DNA-damage response pathway is involved in leptomeningeal metastasis of non-small cell lung cancer","volume":"24","author":"Fan","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-009-9819-2","article-title":"Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma","volume":"94","author":"Groves","year":"2009","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjc.6601953","article-title":"Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value","volume":"91","author":"Herrlinger","year":"2004","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.nec.2020.06.010_bib32","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/01.wnl.0000178981.39984.c2","article-title":"CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases","volume":"65","author":"Reijneveld","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nec.2020.06.010_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.nec.2020.06.010_bib34","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-19-2840","article-title":"Proteomic analysis of CSF from patients with leptomeningeal melanoma metastases identifies signatures associated with disease progression and therapeutic resistance","author":"Smalley","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.nec.2020.06.010_bib35","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/ijms17122142","article-title":"Tumour heterogeneity: the key advantages of single-cell analysis","volume":"17","author":"Tellez-gabriel","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.nec.2020.06.010_bib36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41556-018-0236-7","article-title":"Tumour heterogeneity and metastasis at single-cell resolution","volume":"20","author":"Lawson","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2014.235457","article-title":"Brain tumor mutations detected in cerebral spinal fluid","volume":"61","author":"Pan","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.nec.2020.06.010_bib39","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdy009","article-title":"Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy","volume":"29","author":"Li","year":"2018","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jtho.2019.01.007","article-title":"Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in ALK-rearranged NSCLC","volume":"14","author":"Zheng","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"8","key":"10.1016\/j.nec.2020.06.010_bib42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/1568009618666181017114111","article-title":"Osimertinib quantitative and gene variation analyses in cerebrospinal fluid and plasma of a non-small cell lung cancer patient with leptomeningeal metastases","volume":"19","author":"Song","year":"2019","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12885-019-5348-3","article-title":"Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases","volume":"19","author":"Ge","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11523-019-00645-5","article-title":"Digital PCR-based detection of EGFR mutations in paired plasma and CSF samples of lung adenocarcinoma patients with central nervous system metastases","volume":"14","author":"Huang","year":"2019","journal-title":"Target Oncol"},{"key":"10.1016\/j.nec.2020.06.010_bib45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fonc.2019.00628","article-title":"Afatinib for advanced non-small cell lung cancer in a case with an uncommon epidermal growth factor receptor mutation (G719A) identified in the cerebrospinal fluid","volume":"9","author":"Ma","year":"2019","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jtho.2019.11.024","article-title":"Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression","volume":"15","author":"Aldea","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib47","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1212\/WNL.0000000000008751","article-title":"Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases","volume":"94","author":"van Bussel","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1759-7714.13300","article-title":"Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples","volume":"11","author":"Ma","year":"2020","journal-title":"Thorac Cancer"},{"issue":"7","key":"10.1016\/j.nec.2020.06.010_bib49","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jtho.2018.03.018","article-title":"Recurrently mutated genes differ between leptomeningeal and solid lung cancer brain metastases","volume":"13","author":"Li","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib50","doi-asserted-by":"crossref","first-page":"e000253","DOI":"10.1136\/esmoopen-2017-000253","article-title":"Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases","volume":"2","author":"Siravegna","year":"2017","journal-title":"ESMO Open"},{"issue":"20","key":"10.1016\/j.nec.2020.06.010_bib51","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid","volume":"34","author":"Pentsova","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-016-2081-5","article-title":"Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases","volume":"128","author":"Li","year":"2016","journal-title":"J\u00a0Neurooncol"},{"issue":"7","key":"10.1016\/j.nec.2020.06.010_bib53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/nly046","article-title":"Evaluating circulating tumor DNA from the cerebrospinal fluid of patients with melanoma and leptomeningeal disease","volume":"77","author":"Ballester","year":"2018","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"51","key":"10.1016\/j.nec.2020.06.010_bib54","doi-asserted-by":"crossref","first-page":"85430","DOI":"10.18632\/oncotarget.13397","article-title":"Quantification of tumor-derived cell free DNA (cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies","volume":"7","author":"Momtaz","year":"2016","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.nec.2020.06.010_bib55","doi-asserted-by":"crossref","first-page":"e121718","DOI":"10.1172\/jci.insight.121718","article-title":"Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV","volume":"3","author":"Farhadian","year":"2018","journal-title":"JCI Insight"},{"issue":"368","key":"10.1016\/j.nec.2020.06.010_bib56","doi-asserted-by":"crossref","first-page":"368ra172","DOI":"10.1126\/scitranslmed.aag0976","article-title":"AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases","volume":"8","author":"Yang","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(98)00115-0","article-title":"A\u00a0simple, reproducible technique for establishing leptomeningeal tumors in nude rats","volume":"85","author":"Janczewski","year":"1998","journal-title":"J\u00a0Neurosci Methods"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/1535-7163.MCT-16-0522","article-title":"MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer","volume":"16","author":"Nanjo","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib59","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jtho.2020.01.001","article-title":"Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer","volume":"15","author":"Arai","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11A","key":"10.1016\/j.nec.2020.06.010_bib60","first-page":"144","article-title":"NCCN clinical practice guidelines for carcinomatous\/lymphomatous meningitis","volume":"13","author":"Grossman","year":"1999","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2000.1574","article-title":"Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine","volume":"84","author":"Jaeckle","year":"2001","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005803918194","article-title":"Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy","volume":"35","author":"Chamberlain","year":"1997","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","article-title":"Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy","volume":"7","author":"Morris","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00066-011-0025-8","article-title":"Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors","volume":"188","author":"Gani","year":"2012","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"10.1016\/j.nec.2020.06.010_bib65","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.prro.2017.05.002","article-title":"Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: effectiveness and toxicity after photon or proton treatment","volume":"7","author":"Gunther","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib66","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijrobp.2014.08.004","article-title":"Comprehensive craniospinal radiation for controlling central nervous system leukemia","volume":"90","author":"Walker","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib67","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","article-title":"Carcinoma meningitis secondary to non\u2013small cell lung cancer: combined modality therapy","volume":"55","author":"Chamberlain","year":"1998","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.nec.2020.06.010_bib68","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000322661","article-title":"Clinical recommendations of DEGRO and AGO on preferred standard palliative radiotherapy of bone and cerebral metastases, metastatic spinal cord compression, and leptomeningeal carcinomatosis in breast cancer","volume":"5","author":"Souchon","year":"2010","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11912-003-0083-x","article-title":"Standard and novel radiotherapeutic approaches to neoplastic meningitis","volume":"5","author":"Chang","year":"2003","journal-title":"Curr Oncol Rep"},{"issue":"9701","key":"10.1016\/j.nec.2020.06.010_bib70","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(09)61299-X","article-title":"CNS complications of radiotherapy and chemotherapy","volume":"374","author":"Soussain","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.nec.2020.06.010_bib71","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.30214","article-title":"Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study","volume":"139","author":"Pan","year":"2016","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.nec.2020.06.010_bib72","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00432-010-0831-x","article-title":"Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis","volume":"136","author":"Oechsle","year":"2010","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis--the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2020.06.010_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ctrv.2015.12.004","article-title":"Therapy of leptomeningeal metastasis in solid tumors","volume":"43","author":"Mack","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-013-1092-8","article-title":"A\u00a0retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer","volume":"113","author":"Le Rhun","year":"2013","journal-title":"J\u00a0Neurooncol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-012-0879-3","article-title":"Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors","volume":"109","author":"Segura","year":"2012","journal-title":"J\u00a0Neurooncol"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib77","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","article-title":"High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?","volume":"16","author":"Glantz","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-005-9044-6","article-title":"Systemic high-dose intravenous methotrexate for central nervous system metastases","volume":"78","author":"Lassman","year":"2006","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-007-9409-0","article-title":"Capecitabine therapy of central nervous system metastases from breast cancer","volume":"85","author":"Ekenel","year":"2007","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:NEON.0000003752.89814.ca","article-title":"Response of neoplastic meningitis from solid tumors to oral capecitabine","volume":"65","author":"Giglio","year":"2003","journal-title":"J\u00a0Neurooncol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejim.2008.04.015","article-title":"Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer","volume":"20","author":"Paydas","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1215\/S1152851703000334","article-title":"Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy","volume":"6","author":"Rogers","year":"2004","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib83","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cllc.2017.01.013","article-title":"Pulsatile erlotinib in EGFR-positive non-small-cell lung cancer patients with leptomeningeal and brain metastases: review of the literature","volume":"18","author":"How","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib84","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JCO.1984.2.5.365","article-title":"Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside","volume":"2","author":"Frick","year":"1984","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.nec.2020.06.010_bib85","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0142(19930715)72:2<439::AID-CNCR2820720220>3.0.CO;2-4","article-title":"The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients","volume":"72","author":"Morra","year":"1993","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.nec.2020.06.010_bib86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.nrl.0000219732.33321.cc","article-title":"Neoplastic meningitis","volume":"12","author":"Chamberlain","year":"2006","journal-title":"Neurologist"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib87","first-page":"694","article-title":"Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases","volume":"87","author":"Chamberlain","year":"1997","journal-title":"J\u00a0Neurosurg"},{"issue":"9","key":"10.1016\/j.nec.2020.06.010_bib88","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","article-title":"Neoplastic meningitis","volume":"13","author":"Chamberlain","year":"2008","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib89","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0030-1255220","article-title":"Leptomeningeal metastasis","volume":"30","author":"Chamberlain","year":"2010","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib90","first-page":"216","article-title":"Ommaya reservoir-related infections: clinical manifestations and treatment outcomes","volume":"68","author":"Szvalb","year":"2014","journal-title":"J\u00a0Infect"},{"issue":"18","key":"10.1016\/j.nec.2020.06.010_bib91","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.nec.2020.06.010_bib92","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","article-title":"Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy","volume":"82","author":"Bokstein","year":"1998","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib93","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijc.28949","article-title":"An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients","volume":"136","author":"An","year":"2015","journal-title":"Int J Cancer"},{"issue":"3 Pt 1","key":"10.1016\/j.nec.2020.06.010_bib94","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.40.3_Part_1.435","article-title":"Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain","volume":"40","author":"Chamberlain","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1941874415591702","article-title":"Nonenhancing leptomeningeal metastases: imaging characteristics and potential causative factors","volume":"6","author":"Hatzoglou","year":"2016","journal-title":"Neurohospitalist"},{"issue":"12","key":"10.1016\/j.nec.2020.06.010_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp Mol Med"},{"issue":"9","key":"10.1016\/j.nec.2020.06.010_bib97","first-page":"1976","article-title":"Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab","volume":"259","author":"Bot","year":"2012","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.nec.2020.06.010_bib98","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/annonc\/mdw134","article-title":"Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma","volume":"27","author":"Geukes foppen","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib99","doi-asserted-by":"crossref","first-page":"e000283","DOI":"10.1136\/esmoopen-2017-000283","article-title":"Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2","volume":"3","author":"Glitza","year":"2018","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11060-019-03121-2","article-title":"Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)","volume":"142","author":"Ferguson","year":"2019","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2020.06.010_bib101","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2019.05.019","article-title":"Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors","volume":"116","author":"Hendriks","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib102","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cllc.2019.07.012","article-title":"Four-year lasting sustained complete response after nivolumab in a patient with non-small-cell lung cancer and confirmed leptomeningeal carcinomatosis: changing the paradigm","volume":"21","author":"Bover","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.nec.2020.06.010_bib103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2017.02.022","article-title":"Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient","volume":"108","author":"Gion","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.nec.2020.06.010_bib104","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.lungcan.2016.05.031","article-title":"Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases","volume":"98","author":"Dudnik","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.nec.2020.06.010_bib105","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.2018.36.15_suppl.2007","article-title":"Phase II study of pembrolizumab in leptomeningeal carcinomatosis","volume":"36","author":"Brastianos","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.nec.2020.06.010_bib106","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.6004\/jnccn.2017.0166","article-title":"NCCN guidelines insights: central nervous system cancers, version 1.2017","volume":"15","author":"Nabors","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.nec.2020.06.010_bib107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fonc.2016.00049","article-title":"Systemic immunotherapy for the treatment of brain metastases","volume":"6","author":"Cohen","year":"2016","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.nec.2020.06.010_bib108","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2014.12.FOCUS14758","article-title":"Therapeutic strategies to improve drug delivery across the blood-brain barrier","volume":"38","author":"Azad","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"31","key":"10.1016\/j.nec.2020.06.010_bib109","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1073\/pnas.0604318103","article-title":"Noninvasive localized delivery of herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption","volume":"103","author":"Kinoshita","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"343","key":"10.1016\/j.nec.2020.06.010_bib110","doi-asserted-by":"crossref","first-page":"343re2","DOI":"10.1126\/scitranslmed.aaf6086","article-title":"Clinical trial of blood-brain barrier disruption by pulsed ultrasound","volume":"8","author":"Carpentier","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib111","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib112","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1038\/s41598-018-27335-y","article-title":"Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases","volume":"8","author":"O'reilly","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib113","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1389201019666180418095526","article-title":"CAR T-cell therapy: a new era in cancer immunotherapy","volume":"19","author":"Miliotou","year":"2018","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/1078-0432.CCR-17-2041","article-title":"Regional delivery of chimeric antigen receptor-engineered T cells effectively targets HER2 breast cancer metastasis to the brain","volume":"24","author":"Priceman","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.nec.2020.06.010_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-018-0391-1","article-title":"Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option","volume":"6","author":"Rohaan","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"issue":"11","key":"10.1016\/j.nec.2020.06.010_bib116","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/2326-6066.CIR-15-0071","article-title":"Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: a case report","volume":"3","author":"Glitza","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"10.1016\/j.nec.2020.06.010_bib117","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00262-019-02307-x","article-title":"Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2","volume":"68","author":"Nguyen","year":"2019","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.nec.2020.06.010_bib118","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","article-title":"ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases","volume":"26","author":"Kumthekar","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368020300620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368020300620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:02:50Z","timestamp":1760904170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368020300620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1042368020300620"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2020.06.010","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptomeningeal Carcinomatosis","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}